Home | My Account | Online Store | Contact & Demand | Press Room | About Us | FAQs
Home
Buy & Subscribe
Special Features
Products & Services
Online Store
Products by category
Products by publisher
Product lines
News Channels
Biotechnology
Therapeutic Areas
Business
RSS Feeds
Free RSS News
Get the latest news direct
to your desktop
feed image

Search in our News Channels

Cheap OEM Software
  

Search in our Online Store
Drug Delivery
Filter     Order     Display # 
Date Item Title
05 Apr 2007 Innocoll Receives FDA Approval to Commence Phase 2 Clinical Development with its CollaRx(R) BUPIVACAINE IMPLANT for the Management of Post-operative Pain
05 Apr 2007 pSivida signs A$203 million (US$165 million)
30 Mar 2007 Emisphere Technologies, Inc. Reports Clinical Data on Oral Delivery of GLP-1 and PYY
27 Mar 2007 Cephalon, Inc. (CEPH) Files Marketing Application for Approval of a Fentanyl Effervescent Buccal Tablet in Europe
24 Mar 2007 NovaDel's European Formulation of Ondansetron Targeted for U.S. Zensana(TM)
21 Mar 2007 Dharma Therapeutic Shows IDDS is Effective in Reducing Pain Associated with Insertion of an Intravenous Catheter in their Phase 2 Clinical Trial
21 Mar 2007 Abraxis BioScience to Initiate Two Phase I/II Clinical Trials with nab-docetaxel in Hormone Refractory Prostate and Metastatic Breast Cancer
10 Mar 2007 SCOLR Pharma Announces Research Collaboration with BioCryst Pharmaceuticals
09 Mar 2007 Depomed Completes Patient Enrollment In Phase 3 Clinical Trial Of Gabapentin Gr In Postherpetic Neuralgia
08 Mar 2007 ZymoGenetics Provides Update on rhThrombin Development Plans
07 Mar 2007 ProNAi and Novosom AG Announce Collaboration to Enable Delivery of DNAi-based Cancer Therapeutics
06 Mar 2007 YM BioSciences completes enrolment of AeroLEF(TM) Phase IIB pain trial
28 Feb 2007 Nautilus Biotech announces IND filing for Belerofon, its oral, long-lasting, Interferon-alpha drug
28 Feb 2007 Initiation of Phase III Program Using Emisphere's eligen(R) Technology for Oral Salmon Calcitonin
22 Feb 2007 Allegiance Equity Corporation Announces Positive Results of In Vitro Studies and an Open Label Trial for Relieva(R) in Treating Atopic Dermatitis
22 Feb 2007 Breakthrough oral delivery for arthritis sufferers
21 Feb 2007 Bentley Announces Approval and Expansion of Its Nasulin Phase II Studies in India
15 Feb 2007 Halozyme Therapeutics and Baxter Present Promising Results for the Use of HYLENEX from the Infuse-Morphine Study
14 Feb 2007 InSite Vision Announces Positive Top-Line Safety Results from Phase 1 AzaSite Plus Clinical Study
06 Feb 2007 Wyeth Pharmaceuticals and MediVas Announce Research Partnership to Develop Advanced Hemophilia Therapies
03 Feb 2007 Biodelivery Sciences Announces FDA Acceptance of Bioral Amphotericin IND
02 Feb 2007 Successful Oral Insulin Toxicity Result - Oradel(TM), Loaded With Generic Insulin
01 Feb 2007 MediVas Announces Agreement with Merck in Area of Biologics
01 Feb 2007 Lab International Initiates Patient Enrollment In The Extension Of Its Phase IIB Fentanyl Taifun(R) Trial
01 Feb 2007 NeuroDerm's Transdermal L-DOPA Parkinson’s Patch Completes First Clinical Trial
31 Jan 2007 OctoPlus initiates Locteron Phase II clinical study in chronic hepatitis C
26 Jan 2007 Altea Therapeutics Announces Positive Clinical Results for its Basal Insulin Transdermal Patch
25 Jan 2007 MediVas Announces Signing of Collaboration Agreement with Pfizer
23 Jan 2007 Halozyme Therapeutics Releases Results of Enhanze Technology Clinical Trial to Improve the Subcutaneous Absorption of a Large Protein Molecule Therapeutic
20 Jan 2007 Penwest Begins Next Study in Development of Nalbuphine ER
19 Jan 2007 Alexza Completes Enrollment in AZ-004 Phase IIa Clinical Trial in Schizophrenic Patients with Acute Agitation
17 Jan 2007 Merrion Announces Positive Clinical Results for Osteoporosis Drug MER 103
17 Jan 2007 Hana Biosciences Receives Orphan Drug Designation for Marqibo (Vincristine Sulfate Liposomes Injection) for the Treatment of Acute Lymphoblastic Leukemia
10 Jan 2007 Mirus Bio Corporation Enters Into Agreement with Pfizer Inc to Evaluate RNAi Delivery Technology
10 Jan 2007 Alnylam and Inex Form Strategic Technology Alliance to Discover and Develop RNAi Therapeutics with Lipid-Based Delivery Formulations
09 Jan 2007 Alkermes and Lilly Expand AIR(R) Inhaled Insulin Collaboration
04 Jan 2007 DURECT Starts Phase II Dosing for TRANSDUR(TM)-Bupivacaine (DUR-843)
27 Dec 2006 ADVENTRX Cleared to Initiate Vinorelbine Emulsion Bioequivalence Study
22 Dec 2006 Alexza Pharmaceuticals Announces Initial Results for the AZ-003 Phase I Clinical Trial
22 Dec 2006 A.P. Pharma Resets APF530 NDA Filing Expectations
13 Dec 2006 Apollo oral insulin update
07 Dec 2006 Nastech Announces Positive Phase 1 Clinical Results of Insulin Nasal Spray Compared to Exubera(R) Inhalation Powder and NovoLog(C) Insulin Aspart Injection
01 Dec 2006 Eligard® Six-Month Formulation Approved In Germany
28 Nov 2006 Questcor Announces Initiation of Clinical Program for QSC-001
21 Nov 2006 Aradigm Announces the Results of the AERx HCQ Asthma Phase 2a Study
21 Nov 2006 Gliadel(R) Wafer Clinical Data Presented at Society for Neuro-Oncology Meeting
21 Nov 2006 Altus Pharmaceuticals reports positive ALTU-237 Pre-clinical data for reducing hyperoxaluria, a precusor to kidney stone formation
21 Nov 2006 PARI and Kamada Collaborate to Develop Inhaled Alpha-1 Antitrypsin
21 Nov 2006 Introgen's Novel Nanoparticle Tumor Suppressor NPRL2 Shows Promise in the Treatment of Drug Resistant Cancers
17 Nov 2006 Sonus Pharmaceuticals Announces Completion of Patient Enrollment in Phase 3 Pivotal Trial of TOCOSOL® Paclitaxel in Metastatic Breast Cancer
 
<< Start < Prev 1 2 3 4 5 6 7 8 9 Next > End >>
Results 151 - 200 of 412

PipelineReview.com is powered by La Merie Business Intelligence La Merie Business Intelligence

For immediate assistance, please call us during business hours: Mon-Fri 09:00am - 18:30pm; GMT+01

La Merie S.L | Passatge Jordi Ferran, 20 | E-08028 Barcelona | T +34 93 342 91 97 | F +34 93 342 91 98 | Email info@lamerie.com | Internet www.lamerie.com
All contents © by La Merie S. L

Competitor Analysis Series

Diabetes Drug Pipeline

Order Now

Brief Report Series

CD40 and CD40L (CD154) Agonists & Antagonists

Order Now

Subscribe La Merie Biologics